Skip to content
10-Q

Quarterly Report

ELECTROMEDICAL TECHNOLOGIES, INC. EMED

0001410578-24-001009

← back to feed
Filed
Jun 14, 2024 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · Jun 13, 2024 566.11M sh
Shares Diluted Q1 2024 · Mar 31, 2024 464.82M sh
Shares Diluted Q1 2024 · Mar 31, 2023 240.57M sh
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$158.36K
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$452.74K
Cash And Equivalents Q1 2024 · Mar 31, 2024 $78.84K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $87.7K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$3.69M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$2.87M
Stockholders Equity Q1 2024 · Mar 31, 2023 −$1.03M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$2.22M
Current Liabilities Q1 2024 · Mar 31, 2024 $4.15M
Current Liabilities Q1 2024 · Dec 31, 2023 $3.36M
Total Liabilities Q1 2024 · Mar 31, 2024 $4.4M
Total Liabilities Q1 2024 · Dec 31, 2023 $3.62M
Current Assets Q1 2024 · Mar 31, 2024 $419.38K
Current Assets Q1 2024 · Dec 31, 2023 $449.19K
Total Assets Q1 2024 · Mar 31, 2024 $707.02K
Total Assets Q1 2024 · Dec 31, 2023 $748.38K
Eps Diluted Q1 2024 · Mar 31, 2024 −$0.00
Eps Diluted Q1 2024 · Mar 31, 2023 −$0.00
Eps Basic Q1 2024 · Mar 31, 2024 −$0.00
Eps Basic Q1 2024 · Mar 31, 2023 −$0.00
Sga Expense Q1 2024 · Mar 31, 2024 $372.26K
Sga Expense Q1 2024 · Mar 31, 2023 $1.55M
Net Income Q1 2024 · Mar 31, 2024 −$836.27K
Net Income Q1 2024 · Mar 31, 2023 −$456.06K
Operating Income Q1 2024 · Mar 31, 2024 −$154.88K
Operating Income Q1 2024 · Mar 31, 2023 −$1.26M
Gross Profit Q1 2024 · Mar 31, 2024 $217.39K
Gross Profit Q1 2024 · Mar 31, 2023 $290.95K
Cost Of Revenue Q1 2024 · Mar 31, 2024 $72.86K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $87.7K
Revenue Q1 2024 · Mar 31, 2024 $290.24K
Revenue Q1 2024 · Mar 31, 2023 $378.65K